Last updated: May 14, 2025
Sponsor: Seattle Children's Hospital
Overall Status: Active - Recruiting
Phase
N/A
Condition
Ulcerative Colitis
Irritable Bowel Syndrome (Ibs)
Esophageal Disorders
Treatment
Colonoscopy w/ biopsy
Esophagogastroduodenoscopy (EGD) with biopsy
Clinical Study ID
NCT06315179
STUDY00004616
Ages 6-21 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Suspected diagnosis of CD (Crohn's Disease), UC (Ulcerative Colitis) orIndeterminate colitis (IC)
Exclusion
Exclusion Criteria:
Evidence of Other Complicating Medical Issues:
Other serious medical conditions, such as neurological, liver, kidney, or systemicdisease
Pregnancy
Tobacco, alcohol, or illicit drug abuse
Study Design
Total Participants: 200
Treatment Group(s): 2
Primary Treatment: Colonoscopy w/ biopsy
Phase:
Study Start date:
May 10, 2024
Estimated Completion Date:
January 31, 2030
Study Description
Connect with a study center
Seattle Children's Hospital
Seattle, Washington 98105
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.